230 related articles for article (PubMed ID: 15537754)
1. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain.
Lowe R; Pountney DL; Jensen PH; Gai WP; Voelcker NH
Protein Sci; 2004 Dec; 13(12):3245-52. PubMed ID: 15537754
[TBL] [Abstract][Full Text] [Related]
2. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
Bharathi ; Indi SS; Rao KS
Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
[TBL] [Abstract][Full Text] [Related]
4. Forcing nonamyloidogenic beta-synuclein to fibrillate.
Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
[TBL] [Abstract][Full Text] [Related]
5. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
[TBL] [Abstract][Full Text] [Related]
6. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
Biochemistry; 2004 Dec; 43(51):16233-42. PubMed ID: 15610017
[TBL] [Abstract][Full Text] [Related]
7. Structural evidence for alpha-synuclein fibrils using in situ atomic force microscopy.
Zhang F; Ji LN; Tang L; Hu J; Hu HY; Xu HJ; He JH
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):113-8. PubMed ID: 15685368
[TBL] [Abstract][Full Text] [Related]
8. Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.
Pountney DL; Voelcker NH; Gai WP
Neurotox Res; 2005; 7(1-2):59-67. PubMed ID: 15639798
[TBL] [Abstract][Full Text] [Related]
9. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
10. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
11. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
[TBL] [Abstract][Full Text] [Related]
12. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.
Murray IV; Giasson BI; Quinn SM; Koppaka V; Axelsen PH; Ischiropoulos H; Trojanowski JQ; Lee VM
Biochemistry; 2003 Jul; 42(28):8530-40. PubMed ID: 12859200
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
[TBL] [Abstract][Full Text] [Related]
14. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
[TBL] [Abstract][Full Text] [Related]
15. Effect of metals on herbicides-alpha-synuclein association: a possible factor in neurodegenerative disease studied by capillary electrophoresis.
André C; Truong TT; Robert JF; Guillaume YC
Electrophoresis; 2005 Sep; 26(17):3256-64. PubMed ID: 16143978
[TBL] [Abstract][Full Text] [Related]
16. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
17. Annular alpha-synuclein species from purified multiple system atrophy inclusions.
Pountney DL; Lowe R; Quilty M; Vickers JC; Voelcker NH; Gai WP
J Neurochem; 2004 Jul; 90(2):502-12. PubMed ID: 15228606
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.
Lashuel HA; Petre BM; Wall J; Simon M; Nowak RJ; Walz T; Lansbury PT
J Mol Biol; 2002 Oct; 322(5):1089-102. PubMed ID: 12367530
[TBL] [Abstract][Full Text] [Related]
19. Dependence of alpha-synuclein aggregate morphology on solution conditions.
Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
[TBL] [Abstract][Full Text] [Related]
20. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]